moxifloxacin has been researched along with Candidiasis in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gou, C; Li, C; Li, XZ; Li, YR; Liu, HY; Liu, JC; Piao, HR; Zhang, ML; Zheng, CJ | 1 |
| Kim, KH; Kim, MJ; Kim, S; Le, VH; Lee, JA; Lee, JH; Lee, S; Park, JH; Tchah, H | 1 |
| Akyürek, N; Deren, YT; Hasanreisoğlu, B; Kalkanci, A; Ozdek, S | 1 |
| Fidan, I; Gürelik, F; Kalkanci, A; Kustimur, S; Ozdek, S; Yalçin, B | 1 |
| Alteraz, H; Blau, H; Fabian, I; Horev-Azaria, L; Kariv, N; Kletter, Y; Shalit, I; Shechtman, I | 1 |
5 other study(ies) available for moxifloxacin and Candidiasis
| Article | Year |
|---|---|
Synthesis and antimicrobial evaluation of 5-aryl-1,2,4-triazole-3-thione derivatives containing a rhodanine moiety.
Topics: Anti-Infective Agents; Candida albicans; Candidiasis; Escherichia coli; Escherichia coli Infections; Humans; Rhodanine; Staphylococcal Infections; Staphylococcus aureus; Thiones; Triazoles | 2015 |
Two-photon microscopy of fungal keratitis-affected rabbit cornea ex vivo using moxifloxacin as a labeling agent.
Topics: Animals; Aspergillosis; Candidiasis; Diagnostic Techniques, Ophthalmological; Disease Models, Animal; Eye Infections, Fungal; Imaging, Three-Dimensional; Keratitis; Microscopy, Confocal; Microscopy, Fluorescence; Moxifloxacin; Rabbits; Staining and Labeling | 2018 |
Comparison of antifungal efficacies of moxifloxacin, liposomal amphotericin B, and combination treatment in experimental Candida albicans endophthalmitis in rabbits.
Topics: Amphotericin B; Animals; Antifungal Agents; Aza Compounds; Candida albicans; Candidiasis; Colony Count, Microbial; Disease Models, Animal; Drug Resistance, Fungal; Drug Therapy, Combination; Endophthalmitis; Eye Diseases; Eye Infections, Bacterial; Eye Infections, Fungal; Fluoroquinolones; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Rabbits; Vitreous Body | 2010 |
[In vitro synergistic effect of moxifloxacin and amphotericin B combination against Candida strains].
Topics: Amphotericin B; Anti-Infective Agents; Antifungal Agents; Aza Compounds; Candida; Candidiasis; Drug Synergism; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Moxifloxacin; Quinolines | 2010 |
Immunomodulatory and protective effects of moxifloxacin against Candida albicans-induced bronchopneumonia in mice injected with cyclophosphamide.
Topics: Animals; Anti-Infective Agents; Aza Compounds; Body Weight; Bronchopneumonia; Candidiasis; Ceftazidime; Cephalosporins; Cyclophosphamide; Cytokines; Fluoroquinolones; Lung; Male; Mice; Mice, Inbred BALB C; Moxifloxacin; Neutropenia; Protein Synthesis Inhibitors; Quinolines; Survival | 2002 |